Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023241 (
Legionella
)
6,990
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Microbial pathogens employ sophisticated virulence strategies to cause infections in humans. The intracellular pathogen
Legionella
pneumophila
encodes RidL to hijack the host scaffold protein
VPS29
, a component of retromer and retriever complexes critical for endosomal cargo recycling. Here, we determined the crystal structure of
L. pneumophila
RidL in complex with the human
VPS29
-VPS35 retromer subcomplex. A hairpin loop protruding from RidL inserts into a conserved pocket on
VPS29
that is also used by cellular ligands, such as Tre-2/Bub2/Cdc16 domain family member 5 (TBC1D5) and VPS9-ankyrin repeat protein for
VPS29
binding. Consistent with the idea of molecular mimicry in protein interactions, RidL outcompeted TBC1D5 for binding to
VPS29
. Furthermore, the interaction of RidL with retromer did not interfere with retromer dimerization but was essential for association of RidL with retromer-coated vacuolar and tubular endosomes. Our work thus provides structural and mechanistic evidence into how RidL is targeted to endosomal membranes.
...
PMID:Molecular mechanism for the subversion of the retromer coat by the
Legionella
effector RidL. 2922 24
Retrograde vesicle trafficking pathways are responsible for returning membrane-associated components from endosomes to the Golgi apparatus and the endoplasmic reticulum (ER), and they are critical for maintaining organelle identity, lipid homeostasis, and many other cellular functions. The retrograde transport pathway has emerged as an important target for intravacuolar bacterial pathogens. The opportunistic pathogen
Legionella
pneumophila
exploits both the secretory and recycling branches of the vesicle transport pathway for intracellular bacterial proliferation. Its Dot/Icm effector RidL inhibits the activity of the retromer by directly engaging retromer components. However, the mechanism underlying such inhibition remains unknown. Here we present the crystal structure of RidL in complex with
VPS29
, a subunit of the retromer. Our results demonstrate that RidL binds to a highly conserved hydrophobic pocket of
VPS29
. This interaction is critical for endosomal recruitment of RidL and for its inhibitory effects. RidL inhibits retromer activity by direct competition, in which it occupies the
VPS29
-binding site of the essential retromer regulator TBC1d5. The mechanism of retromer inhibition by RidL reveals a hotspot on
VPS29
critical for recognition by its regulators that is also exploited by pathogens, and provides a structural basis for the development of small molecule inhibitors against the retromer.
...
PMID:Mechanism of inhibition of retromer transport by the bacterial effector RidL. 2938 89